SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+8.82%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$234M
AUM Growth
+$234M
(+45%)
Cap. Flow
+$60M
Cap. Flow
% of AUM
25.59%
Top 10 Holdings %
Top 10 Hldgs %
47.23%
Holding
82
New
25
Increased
16
Reduced
9
Closed
15
Top Buys
| 1 |
GSK
GSK
|
$14.6M |
| 2 |
Bionano Genomics
BNGO
|
$7.35M |
| 3 |
UROV
Urovant Sciences Ltd.
UROV
|
$7.1M |
| 4 |
Biogen
BIIB
|
$6.82M |
| 5 |
Premier
PINC
|
$6.61M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$5.97M |
| 2 |
Elevance Health
ELV
|
$5.15M |
| 3 |
Icon
ICLR
|
$4.94M |
| 4 |
Willis Towers Watson
WTW
|
$3.94M |
| 5 |
Revvity
RVTY
|
$3.85M |
Sector Composition
| 1 | Healthcare | 92.14% |
| 2 | Financials | 5.23% |
| 3 | Technology | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GSK
GSK
$79.9B
| $14.6M | 5.02% | +363,960 | New | +$14.6M |
|
2
Cigna
CI
$80.3B
| $14M | 4.82% | 67,449 +28,249 | +72% | +$5.88M |
|
3
Kura Oncology
KURA
$686M
| $12.7M | 4.37% | 727,258 -110,346 | -13% | -$1.93M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $12.3M | 4.21% | 60,444 +21,309 | +54% | +$4.32M |
|
5
Sanofi
SNY
$121B
| $11.9M | 4.08% | 266,388 +116,330 | +78% | +$5.2M |
|
6
HCA Healthcare
HCA
$94.5B
| $11.7M | 4% | 83,822 -13,408 | -14% | -$1.87M |
|
7
MEI Pharma
MEIP
$160M
| $9.93M | 3.41% | 2,303,645 +119,659 | +5% | +$516K |
|
8
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.12M | 3.13% | 104,176 +74,341 | +249% | +$6.51M |
|
|
9
Bionano Genomics
BNGO
$17.6M
| $7.35M | 2.52% | +1,440,857 | New | +$7.35M |
|
|
UROV
10
DELISTED
Urovant Sciences Ltd.
UROV
| $7.1M | 2.44% | +591,454 | New | +$7.1M |
|
|
11
Biogen
BIIB
$19.4B
| $6.82M | 2.34% | +19,300 | New | +$6.82M |
|
|
12
Elevance Health
ELV
$71.8B
| $6.8M | 2.33% | 24,803 -18,798 | -43% | -$5.15M |
|
13
Humana
HUM
$36.5B
| $6.79M | 2.33% | 20,054 +2,261 | +13% | +$765K |
|
|
14
Premier
PINC
$2.14B
| $6.61M | 2.27% | +144,412 | New | +$6.61M |
|
15
Gyre Therapeutics
GYRE
$703M
| $5.94M | 2.04% | 550,977 +79,529 | +17% | +$857K |
|
16
Rigel Pharmaceuticals
RIGL
$697M
| $5.92M | 2.03% | 1,843,501 +444,883 | +32% | +$1.43M |
|
17
Universal Health Services
UHS
$11.6B
| $5.29M | 1.82% | 41,393 +6,070 | +17% | +$776K |
|
18
Smith & Nephew
SNN
$16.3B
| $4.98M | 1.71% | +134,388 | New | +$4.98M |
|
19
Novartis
NVS
$245B
| $4.97M | 1.71% | 57,691 +2,691 | +5% | +$232K |
|
|
FOMX
20
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.41M | 1.51% | +770,000 | New | +$4.41M |
|
21
Philips
PHG
$26.2B
| $4.36M | 1.5% | 95,776 -5,966 | -6% | -$272K |
|
|
RVNC
22
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.08M | 1.4% | 164,353 +63,061 | +62% | +$1.57M |
|
23
Viking Therapeutics
VKTX
$3.04B
| $3.72M | 1.27% | 213,252 -68,052 | -24% | -$1.19M |
|
|
ALXN
24
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.58M | 1.23% | +25,785 | New | +$3.58M |
|
|
25
Icon
ICLR
$13.8B
| $3.57M | 1.22% | 23,198 -32,134 | -58% | -$4.94M |
|